Literature DB >> 23726625

Risk factors for recurrent urinary tract infection in kidney transplant recipients.

J-H Lim1, J-H Cho, J-H Lee, Y-J Park, S Jin, G-Y Park, J-S Kim, Y-J Kang, O Kwon, J-Y Choi, C-D Kim, Y-L Kim, H-K Kim, S Huh, S-H Park.   

Abstract

BACKGROUND: Urinary tract infections (UTIs) are the most common infectious complication in kidney transplant recipients (KTRs). The aim of this study to investigate the risk factors for and causative organisms of UTI as well as to evaluate the impact these diseases on allograft function in KTRs.
METHODS: We analyzed patients who underwent kidney transplantation (KT) between January 2000 and December 2010. Among a total of 344 KTRs, 50 (14.5%) patients experienced 106 UTI episodes during a mean follow-up of 35.9 ± 26.0 months. Twenty three patients experiencing recurrent UTI were compared with 27 nonrecurrent UTI patients and with 50 non-UTI patients matched for age, gender, and transplantation date.
RESULTS: The number of patients with renal calculi, diabetes, or prior dialysis was significantly greater among the UTI group compared with control subjects. In addition, the number of patients with renal calculi was significantly higher among the recurrent compared with the nonrecurrent cohort (43.5 vs 7.4%; P = .003). The most common causative organism was Escherichia coli (64.1%), followed by Enterococcus species (20.5%). Higher rates of antibiotic resistance, especially Extended Spectrum Beta-Lactamasc (ESBL) production, were observed among the recurrent compared with the nonrecurrent group (53.1 vs 0%; P = .013). The rate of decline of estimated glomerular filtration rate was significantly faster in the UTI than the non-UTI group, whereas it did not differ between the recurrent and nonrecurrent group.
CONCLUSIONS: Adequate treatment of an initial UTI to prevent as recurrent infection and prolong graft longevity is especially reasonable for KTRs with renal calculi or in cases of antibiotic-resistant microorganisms.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23726625     DOI: 10.1016/j.transproceed.2012.12.011

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  11 in total

1.  Safety and efficacy of methenamine hippurate for the prevention of recurrent urinary tract infections in adult renal transplant recipients: A single center, retrospective study.

Authors:  Ian Hollyer; Francesca Varias; Bing Ho; Michael G Ison
Journal:  Transpl Infect Dis       Date:  2019-03-08       Impact factor: 2.228

2.  Urinary tract infection and Diabetes Mellitus-Etio-clinical profile and antibiogram: A North Indian perspective.

Authors:  Subramani Jagadeesan; Brijendra K Tripathi; Pranav Patel; Subramanian Muthathal
Journal:  J Family Med Prim Care       Date:  2022-05-14

Review 3.  Urinary tract infections in patients with type 2 diabetes mellitus: review of prevalence, diagnosis, and management.

Authors:  Orna Nitzan; Mazen Elias; Bibiana Chazan; Walid Saliba
Journal:  Diabetes Metab Syndr Obes       Date:  2015-02-26       Impact factor: 3.168

4.  Vitamin D deficiency is associated with increased risk of bacterial infections after kidney transplantation.

Authors:  Young-Jae Park; Sang-Un Kim; Kyung-Hee Lee; Jong-Hak Lee; Eugene Kwon; Hee-Yeon Jung; Ji-Young Choi; Jang-Hee Cho; Sun-Hee Park; Yong-Lim Kim; Hyung-Kee Kim; Seung Huh; Chan-Duck Kim
Journal:  Korean J Intern Med       Date:  2016-03-25       Impact factor: 2.884

5.  Epidemiology, susceptibility, and risk factors for acquisition of MDR/XDR Gram-negative bacteria among kidney transplant recipients with urinary tract infections.

Authors:  Xiuhong Yuan; Taohua Liu; Di Wu; Qiquan Wan
Journal:  Infect Drug Resist       Date:  2018-05-14       Impact factor: 4.003

Review 6.  Sodium-glucose cotransporter-2 inhibitors (SGLT2i) in kidney transplant recipients: what is the evidence?

Authors:  Aditi Ujjawal; Brittany Schreiber; Ashish Verma
Journal:  Ther Adv Endocrinol Metab       Date:  2022-04-13       Impact factor: 4.435

Review 7.  Urinary Tract Infections Caused by K. pneumoniae in Kidney Transplant Recipients - Epidemiology, Virulence and Antibiotic Resistance.

Authors:  Beata Krawczyk; Magdalena Wysocka; Michał Michalik; Justyna Gołębiewska
Journal:  Front Cell Infect Microbiol       Date:  2022-04-21       Impact factor: 5.293

8.  Urinary Tract Infections in Kidney Transplant Patients Due to Escherichia coli and Klebsiella pneumoniae-Producing Extended-Spectrum β-Lactamases: Risk Factors and Molecular Epidemiology.

Authors:  Maria José Espinar; Isabel M Miranda; Sofia Costa-de-Oliveira; Rita Rocha; Acácio G Rodrigues; Cidália Pina-Vaz
Journal:  PLoS One       Date:  2015-08-03       Impact factor: 3.240

9.  Risk Factors for Urinary Tract Infections in Renal Allograft Recipients: Experience of a Tertiary Care Center in Hyderabad, South India.

Authors:  M V N L R Mohan; M Neeraja; S Sudhaharan; S B Raju; T Gangadhar; V Lakshmi
Journal:  Indian J Nephrol       Date:  2017 Sep-Oct

Review 10.  Bacterial and Viral Infection and Sepsis in Kidney Transplanted Patients.

Authors:  Alberto Mella; Filippo Mariano; Caterina Dolla; Ester Gallo; Ana Maria Manzione; Maria Cristina Di Vico; Rossana Cavallo; Francesco Giuseppe De Rosa; Cristina Costa; Luigi Biancone
Journal:  Biomedicines       Date:  2022-03-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.